(Q71807450)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7586244%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

title

Factor V Leiden and risks of recurrent idiopathic venous thromboembolism (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7586244%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Factor V Leiden and Risks of Recurrent Idiopathic Venous Thromboembolism (English)

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.10.2800

25 May 2024

1 reference

venous thromboembolism

1 reference

6

C H Hennekens

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7586244%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

3

M J Stampfer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7586244%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1

P M Ridker

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7586244%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

author name string

P. M. Ridker

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7586244

25 May 2024

J. P. Miletich

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7586244

25 May 2024

S. Z. Goldhaber

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7586244

25 May 2024

K. Lindpaintner

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7586244

25 May 2024

language of work or name

English

0 references

publication date

1 November 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7586244%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

15 November 1995

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7586244

full work available at URL

25 May 2024

https://www.ahajournals.org/doi/full/10.1161/01.CIR.92.10.2800

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.10.2800

25 May 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7586244%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

volume

92

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7586244%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7586244%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

page(s)

2800-2802

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7586244%20AND%20SRC:MED&resulttype=core&format=json

Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C

21 October 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.10.2800

Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor V.

25 May 2024

2

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.10.2800

Mutation in blood coagulation factor V associated with resistance to activated protein C.

25 May 2024

3

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.10.2800

Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor V

25 May 2024

4

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.10.2800

Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis

25 May 2024

5

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.10.2800

Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study

25 May 2024

7

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.10.2800

Resistance to activated protein C as a basis for venous thrombosis.

25 May 2024

8

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.10.2800

Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men

25 May 2024

9

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.10.2800

Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation

25 May 2024

10

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.10.2800

Brief report: variability of thrombosis among homozygous siblings with resistance to activated protein C due to an Arg-->Gln mutation in the gene for factor V

25 May 2024

11

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.10.2800

Final report on the aspirin component of the ongoing Physicians' Health Study

25 May 2024

13

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.10.2800

Conceptual problems in the definition and interpretation of attributable fractions

25 May 2024

14

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.10.2800

Warfarin Sodium versus Low-Dose Heparin in the Long-Term Treatment of Venous Thrombosis

25 May 2024

16

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.10.2800

Adjusted subcutaneous heparin versus warfarin sodium in the long-term treatment of venous thrombosis.

25 May 2024

17

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.10.2800

Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis.

25 May 2024

18

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.10.2800

Effect of inhaled furosemide on the bronchial response to lysine-aspirin inhalation in asthmatic subjects

25 May 2024

19

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.10.2800

25 May 2024

Oral anticoagulant drugs

20

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.10.2800

Cost-effectiveness analyses

25 May 2024

21

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.10.2800

The optimal duration of anticoagulant therapy for venous thrombosis

25 May 2024

22

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.10.2800

Deep-vein thrombosis and the incidence of subsequent symptomatic cancer

25 May 2024

23

1 reference

https://api.crossref.org/works/10.1161/01.CIR.92.10.2800

25 May 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7586244%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference